These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10616359)

  • 61. Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir.
    Alcoba M; Cuevas MJ; Perez-Simon MR; Mostaza JL; Ortega L; Ortiz de Urbina J; Carro JA; Raya C; Abad M; Martin V;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):253-8. PubMed ID: 12794563
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of collection method on assessment of semen HIV RNA viral load.
    Osborne BJ; Sheth PM; Kovacs C; Mazzulli T; Kaul R
    PLoS One; 2011; 6(8):e23654. PubMed ID: 21886808
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy.
    Liuzzi G; D'Offizi G; Topino S; Zaccarelli M; Amendola A; Capobianchi MR; Perno CF; Narciso P; Antinori A
    AIDS; 2003 May; 17(7):1089-92. PubMed ID: 12700463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of correlation between seminal and plasma HIV-1 viral loads is associated with CD4 T cell depletion in therapy-naïve HIV-1+ patients.
    Pinto-Neto LF; Vieira NF; Soprani M; Cunha CB; Dietze R; Ribeiro-Rodrigues R
    Mem Inst Oswaldo Cruz; 2002 Jun; 97(4):563-7. PubMed ID: 12118292
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Virologic response associated with a change in protease inhibitor therapy.
    Butcher D; Greene J; Duong P; Markson L
    Arch Intern Med; 2000 Feb; 160(3):394-5. PubMed ID: 10668845
    [No Abstract]   [Full Text] [Related]  

  • 66. Compartmentalization of HIV-1 according to antiretroviral therapy: viral loads are correlated in blood and semen but poorly in blood and saliva.
    Bourlet T; Cazorla C; Berthelot P; Grattard F; Cognasse F; Fresard A; Defontaine C; Lucht FR; Genin C; Pozzetto B
    AIDS; 2001 Jan; 15(2):284-5. PubMed ID: 11216944
    [No Abstract]   [Full Text] [Related]  

  • 67. HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy.
    Graham SM; Holte SE; Dragavon JA; Ramko KM; Mandaliya KN; McClelland RS; Peshu NM; Sanders EJ; Krieger JN; Coombs RW
    PLoS One; 2012; 7(8):e43086. PubMed ID: 22912795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lower genitourinary tract sources of seminal HIV.
    Coombs RW; Lockhart D; Ross SO; Deutsch L; Dragavon J; Diem K; Hooton TM; Collier AC; Corey L; Krieger JN
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):430-8. PubMed ID: 16652050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hair it is: the long and short of monitoring antiretroviral treatment.
    Gandhi M; Greenblatt RM
    Ann Intern Med; 2002 Oct; 137(8):696-7. PubMed ID: 12379072
    [No Abstract]   [Full Text] [Related]  

  • 70. Risk factors for HIV-1 shedding in semen.
    Speck CE; Coombs RW; Koutsky LA; Zeh J; Ross SO; Hooton TM; Collier AC; Corey L; Cent A; Dragavon J; Lee W; Johnson EJ; Sampoleo RR; Krieger JN
    Am J Epidemiol; 1999 Sep; 150(6):622-31. PubMed ID: 10490002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    Palich R; Ghosn J; Chaillon A; Boilet V; Nere ML; Chaix ML; Delobel P; Molina JM; Lucht F; Bouchaud O; Rieux V; Thiebaut R; Levy Y; Delaugerre C; Lelievre JD;
    AIDS; 2019 Feb; 33(2):279-284. PubMed ID: 30325777
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of HIV-1 viral load in seminal plasma samples.
    Dunne AL; Mitchell F; Allen KM; Baker HW; Garland S; Clarke GN; Mijch A; Crowe SM
    J Clin Virol; 2003 Feb; 26(2):239-45. PubMed ID: 12600655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.
    Pasquier C; Sauné K; Raymond S; Moinard N; Daudin M; Bujan L; Izopet J
    J Clin Microbiol; 2009 Sep; 47(9):2883-7. PubMed ID: 19641060
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group.
    Le Moing V; Chêne G; Masquelier B; Sicard D; Brun-Vézinet F; Reynes J; Raffi F
    J Acquir Immune Defic Syndr; 2000 May; 24(1):82-3. PubMed ID: 10877502
    [No Abstract]   [Full Text] [Related]  

  • 75. Amplifying and quantifying HIV-1 RNA in HIV infected individuals with viral loads below the limit of detection by standard clinical assays.
    Mens H; Kearney M; Wiegand A; Spindler J; Maldarelli F; Mellors JW; Coffin JM
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21968801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir.
    Byrn RA; Kiessling AA
    J Reprod Immunol; 1998 Dec; 41(1-2):161-76. PubMed ID: 10213308
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assisted conception in HIV discordant couples: evaluation of semen processing techniques in reducing HIV viral load.
    Chrystie IL; Mullen JE; Braude PR; Rowell P; Williams E; Elkington N; de Ruiter A; Rice K; Kennedy J
    J Reprod Immunol; 1998 Dec; 41(1-2):301-6. PubMed ID: 10213318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assays for the determination of HIV-1 load in semen: a review of indications, methods and performance in vitro.
    Chan DJ; McNally L
    Curr HIV Res; 2008 May; 6(3):182-8. PubMed ID: 18473781
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV-1 Populations in Semen Arise through Multiple Mechanisms.
    Anderson JA; Ping LH; Dibben O; Jabara CB; Arney L; Kincer L; Tang Y; Hobbs M; Hoffman I; Kazembe P; Jones CD; Borrow P; Fiscus S; Cohen MS; Swanstrom R;
    PLoS Pathog; 2010 Aug; 6(8):e1001053. PubMed ID: 20808902
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy.
    Aukrust P; Müller F; Frøland SS
    J Infect Dis; 1998 Apr; 177(4):1091-6. PubMed ID: 9534990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.